Return to homepagePandemic Pact

Supporting WHO's work in epidemic preparedness

  • Funded by Foreign, Commonwealth & Development Office (FCDO)
  • Total publications:2 publications

Grant number: 216002/Z/19/Z

Grant search

Key facts

  • Disease

    Ebola, Marburg virus disease
  • Start & end year

    2022
    2025
  • Known Financial Commitments (USD)

    $2,507,640.85
  • Funder

    Foreign, Commonwealth & Development Office (FCDO)
  • Principal Investigator

    N/A

  • Research Location

    Switzerland
  • Lead Research Institution

    World Health Organization (WHO)
  • Research Priority Alignment

    N/A
  • Research Category

    Infection prevention and control

  • Research Subcategory

    IPC at the human-animal interface

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This project includes twelve diverse areas of work conducted by WHO to increase epidemic preparedness, including the development of an Innovative Rodent Control and Human Health strategy; development of a tool to assess epidemic vulnerability of countries; a scoping plan for design software to link genomic and surveillance data; the use of modern sequencing technologies in outbreak response; defining Standard of Care (SoC) for Ebola and Marburg outbreaks; support to the Zika virus(ZIKV) Individual Participant Data (IPD) Consortium; development of new modules for GO-Data and improved functionality and rollout of training of super-users; gene editing technologies and implications for human health; development of generic protocols prepositioning and training for Ebola vaccines deployment and Ebola therapeutics clinical trials in target countries; development of a Rift Valley Fever (RVF) R&D Roadmap; development of a Zika R&D Roadmap through holding the first Taskforce meeting; and first steps in developing a Meningitis R&D Roadmap. The total cost is 2,510,000 USD The costs are 2,183,700 USD plus 326,300 USD programme support costs (13%).

2 Publications linked via Europe PMC

Heterogeneity of Zika virus exposure and outcome ascertainment across cohorts of pregnant women, their infants and their children: a metadata survey.

The Zika Virus Individual Participant Data Consortium: A Global Initiative to Estimate the Effects of Exposure to Zika Virus during Pregnancy on Adverse Fetal, Infant, and Child Health Outcomes.